Washington roundup: FDA toxicology group wields technology to combat bioterror

Incentives, quality reporting, public participation debated

SmartPill's GI diagnostic enters North America, eyes Europe

Cost-effective technology will reduce health 'unaffordability'

Tough legal issues hover over payment-for-quality terrain

Cost-effective technology could reduce 50% health cost bloat

Incentives, quality reporting, public participation debated

Meeting dips 'foot in water' of tough payment reform plan

Washington roundup: FDA toxicology group wields technology to combat bioterror

Reactions to revised IPPS rule positive but still rather guarded